|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2870157 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13744836.1 |
| Date of filing the European patent application | 2013-07-02 | |
| (97) | Date of publication of the European application | 2015-05-13 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-30 |
| (46) | Date of publication of the claims translation | 2017-12-11 |
| (86) | Number | PCT/IB2013/055434 |
| Date | 2013-07-02 |
| (87) | Number | WO 2014/006572 |
| Date | 2014-01-09 |
| (30) | Number | Date | Country code |
| CH26922012 | 2012-07-04 | IN | |
| CH26932012 | 2012-07-04 | IN | |
| 201261691561 P | 2012-08-21 | US | |
| 201261691586 P | 2012-08-21 | US |
| (72) |
VAKKALANKA, Swaroop Kumar Venkata Satya, CH
MUTHUPPALANIAPPAN, Meyyappan, IN
NAGARATHNAM, Dhanapalan, CH
|
| (73) |
Rhizen Pharmaceuticals S.A.,
Fritz Courvoisier 40, 2300 La Chaux de Fonds,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Selektyvieji PI3K delta inhibitoriai |
| SELECTIVE PI3K DELTA INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2021-06-28 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-07-02 |